Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mangafodipir adjunct to primary PCI in acute myocardial infarction
2009-011485-28Phase 2Completed
- Sponsor
- Egetis Therapeutics
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of mangafodipir in myocardial infarction (MI), sponsored by Egetis Therapeutics. Primary endpoint: Release of CK-MB and troponin T to plasma at 6 hours after PCI. Started Jun 2009; status: completed.
02
Drugs
mangafodipir
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-011485-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011485-28.